In addition to its lead program, Biospherics is applying its
expertise and research
to create a pipeline of
proprietary candidates across a range of therapeutic indications.
See also:
|
|
Clinical TrialsSpherix recently completed a Phase 3 clinical trial to study the use of Naturlose® as a treatment for Type 2 diabetes.
|